metaLead Therapeutics Company
metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Connections
Founded Date:
2023-01-01
Employee Number:
1-10
Headquarters:
Zürich, Zurich, Switzerland, Europe
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Investors:
BioInnovation Institute, UZH Life Sciences Fund, Venture Kick
Ipo Status:
private
City:
Zürich
Region:
Zurich
Country:
Switzerland